ALICE GERMAINE BEUKAM: Open Payments
NPI 1760152763 · WASHINGTON, DC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$402 in 17 payments from 9 companies in 2025. Trend: 2023 $602 · 2024 $1,326 · 2025 $402
Food & beverage: $402
| Company | Payments | Amount |
|---|---|---|
| Janssen Pharmaceuticals, Inc | 3 | $136 |
| E.R. Squibb & Sons, L.L.C. | 5 | $88 |
| Lundbeck LLC | 3 | $66 |
| ABBVIE INC. | 1 | $23 |
| Alkermes, Inc. | 1 | $20 |
| Otsuka America Pharmaceutical, Inc. | 1 | $18 |
| Otsuka Pharmaceutical Development & Commercialization, Inc. | 1 | $18 |
| Indivior Inc. | 1 | $17 |
| Supernus Pharmaceuticals, Inc. | 1 | $16 |
Products named: INVEGA SUSTENNA, COBENFY, ABILIFY MAINTENA, ABILIFY ASIMTUFII, VRAYLAR, ARISTADA, SUBLOCADE, Qelbree.
Industry payments across DC — which companies pay providers there.
